Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Osteoporosis

Free Subscription Articles published in Menopause Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

January 2012
1. CHENG Q , Zhu YX, Zhang MX, Li LH, et al
   Age and sex effects on the association between body composition and bone mineral density in healthy Chinese men and women.
   Menopause. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. MAKKER A , Singh MM, Mishra G, Singh BP, et al
   Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
   Menopause. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. CHO GJ , Shin JH, Yi KW, Park HT, et al
   Adolescent pregnancy is associated with osteoporosis in postmenopausal women.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CHO GJ , Park HT, Shin JH, Hur JY, et al
   The relationship between blood mercury level and osteoporosis in postmenopausal women.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. MLAKAR SJ , Osredkar J, Prezelj J, Marc J, et al
   Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. MARQUES EA , Moreira P, Wanderley F, Pizarro AN, et al
   Appendicular fat mass is positively associated with femoral neck bone mineral density in older women.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. GOLDSTEIN SR , Bhattoa HP, Neven P, Cox DA, et al
   Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BIAN Q , Liu SF, Huang JH, Yang Z, et al
   Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SEBASTIAN-OCHOA A , Fernandez-Garcia D, Reyes-Garcia R, Mezquita-Raya P, et al
   Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate.
   Menopause. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. PALACIOS S , Neyro JL, Ferrer J, Villero J, et al
    Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. LI L , Roddam A, Gitlin M, Taylor A, et al
    Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
12. BACHMANN G , Kriegman A, Goncalves J, Kianifard F, et al
    Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density.
    Menopause. 2011;18:851-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GOLDSTEIN SR
    Bone health medications: research questions versus clinical choices.
    Menopause. 2011;18:835-6.
    PubMed     Text format     Related articles   
    
    
    
    
14. LEGETTE LL , Lee WH, Martin BR, Story JA, et al
    Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects.
    Menopause. 2011;18:923-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
15. ZHAO J , Xia W, Nie M, Zheng X, et al
    The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SCHNATZ PF , Marakovits KA, Dubois M, O'Sullivan DM, et al
    Osteoporosis screening and treatment guidelines: are they being followed?
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. 
    The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    Menopause. 2011;18:732-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KIM H , Choe SA, Ku SY, Kim SH, et al
    Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women.
    Menopause. 2011;18:808-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
19. ZHAO L , Cui B, Liu JM, Zhang MJ, et al
    Interactions of osteoporosis candidate genes for age at menarche, age at natural menopause, and maximal height in Han Chinese women.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
20. SCHNATZ PF , O'Sullivan DM
    Pregnancy, breast-feeding, and the combined effects on the development of postmenopausal osteoporosis: keeping the science moving forward.
    Menopause. 2011;18:591.
    PubMed     Text format     Related articles   
    
    
    
    
21. SIOKA C
    Pregnancy-related effects on postmenopausal osteoporosis.
    Menopause. 2011;18:590-1.
    PubMed     Text format     Related articles   
    
    
    
    
22. BACHMANN G , Crosby U, Feldman RA, Ronkin S, et al
    Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial.
    Menopause. 2011;18:508-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. GOMES DC , Costa-Paiva L, Farhat FC, Pedro AO, et al
    Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass.
    Menopause. 2011;18:531-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. GARCIA-MARTIN A , Cortes-Berdonces M, Luque-Fernandez I, Rozas-Moreno P, et al
    Osteocalcin as a marker of metabolic risk in healthy postmenopausal women.
    Menopause. 2011;18:537-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
25. MEADOWS ES , Whangbo A, McQuarrie N, Gilra N, et al
    Compliance with mammography and bone mineral density screening in women at least 50 years old.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. DONTAS IA , Lelovas PP, Kourkoulis SK, Aligiannis N, et al
    Protective effect of Sideritis euboea extract on bone mineral density and strength of ovariectomized rats.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
27. VALERO C , Zarrabeitia MT, Hernandez JL, Pineda B, et al
    Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. POLLYCOVE R , Naftolin F, Simon JA
    The evolutionary origin and significance of menopause.
    Menopause. 2011;18:336-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KIM HK , Lee S, Leem KH
    Protective effect of egg yolk peptide on bone metabolism.
    Menopause. 2011;18:307-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
30. AGHA-HOSSEINI F , Mirzaii-Dizgah I, Moosavi MS
    Relationship of lumbar spine bone mineral density and oral dryness feeling in menopause.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
31. ZHAO Y , Huai Y, Jin J, Geng M, et al
    Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
    Menopause. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SAYEGH RA
    Screening for postmenopausal osteoporosis after 70 years of age: dual-energy x-ray absorptiometry, radiography, both, or none?
    Menopause. 2011;18:15-6.
    PubMed     Text format     Related articles   
    
    
    
    
33. ARCHER DF
    The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.
    Menopause. 2011;18:6-7.
    PubMed     Text format     Related articles   
    
    
    
    
34. GOLDSTEIN SR , Neven P, Cummings S, Colgan T, et al
    Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes.
    Menopause. 2011;18:17-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
35. VELDHUIS S , Wolbers F, Brouckaert O, Vermes I, et al
    Cancer prevalence in osteoporotic women with low serum vitamin D levels.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
36. ROJANO-MEJIA D , Aguilar-Madrid G, Lopez-Medina G, Cortes-Espinosa L, et al
    Risk factors and impact on bone mineral density in postmenopausal Mexican mestizo women.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. PALOMO L , Buencamino-Francisco MC, Carey JJ, Sivanandy M, et al
    Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women?
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MCCLUNG M
    Is altered bone health part of the metabolic syndrome?
    Menopause. 2010;17:900-1.
    PubMed     Text format     Related articles   
    
    
    
    
39. HERNANDEZ JL , Olmos JM, Pariente E, Martinez J, et al
    Metabolic syndrome and bone metabolism: the Camargo Cohort study.
    Menopause. 2010;17:955-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. YUE J , Zhang X, Dong B, Yang M, et al
    Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.
    Menopause. 2010;17:1071-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
41. DAVIS SR , Kirby C, Weekes A, Lanzafame A, et al
    Simplifying screening for osteoporosis in Australian primary care: the Prospective Screening for Osteoporosis; Australian Primary Care Evaluation of Clinical Tests (PROSPECT) study.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
42. SIDDIQUI JA , Sharan K, Swarnkar G, Rawat P, et al
    Quercetin-6-C-beta-d-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. OZKAYA E , Cakr E, Okuyan E, Cakr C, et al
    Comparison of the effects of surgical and natural menopause on carotid intima media thickness, osteoporosis, and homocysteine levels.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. GALLAGHER JC , Levine JP
    Preventing osteoporosis in symptomatic postmenopausal women.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. SCHNATZ PF , Barker KG, Marakovits KA, O'Sullivan DM, et al
    Effects of age at first pregnancy and breast-feeding on the development of postmenopausal osteoporosis.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LEE DY , Kim H, Ku SY, Kim SH, et al
    Association between polymorphisms in Wnt signaling pathway genes and bone mineral density in postmenopausal Korean women.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BOLANOS R , Francia J
    Isoflavones versus hormone therapy for reduction of vertebral fracture risk: indirect comparison.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
48. LANGSETMO L , Morin S, Kovacs CS, Kreiger N, et al
    Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
49. PANDEY R , Gautam AK, Bhargavan B, Trivedi R, et al
    Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction.
    Menopause. 2010;17:602-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. PINKERTON JV , Goldstein SR
    Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
    Menopause. 2010;17:642-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
51. SHARAN K , Swarnkar G, Siddiqui JA, Kumar A, et al
    A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
52. BEBENEK M , Kemmler W, von Stengel S, Engelke K, et al
    Effect of exercise and Cimicifuga racemosa (CR BNO 1055) on bone mineral density, 10-year coronary heart disease risk, and menopausal complaints: the randomized controlled Training and Cimicifuga racemosa Erlangen study.
    Menopause. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. HWANG JH , Song SH, Lee JK, Lee NW, et al
    Bone mineral density after concurrent chemoradiation in patients with uterine cervical cancer.
    Menopause. 2010;17:416-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SHARAN K , Siddiqui JA, Swarnkar G, Tyagi AM, et al
    Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect.
    Menopause. 2010;17:393-402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
55. ATTAMAN J
    Beyond identifying women at risk for coronary heart disease and osteoporosis.
    Menopause. 2010.
    PubMed     Text format     Related articles   
    
    
    
    January 2010
56. 
    Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause. 2010;17:25-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
57. VOGEL VG
    Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators.
    Menopause. 2009;16:1079-82.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: